Enwave Corporation Stock
€0.25
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | 6.960% | 6.957% | 17.143% | 78.261% | 78.261% | -9.890% | -65.690% |
| Resverlogix Corp | -9.730% | -9.735% | -23.881% | 88.889% | 88.889% | -38.554% | -91.053% |
| Aurinia Pharmaceuticals Inc. | -0.520% | -2.001% | -3.751% | 54.225% | 54.225% | 230.958% | 18.574% |
| Spectral Medical Inc | 1.920% | 1.923% | 3.247% | 148.438% | 148.438% | 220.565% | 194.444% |
News
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
Vancouver, B.C., December 15th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the fourth
EnWave Signs Royalty-Bearing Commercial License with Shinyway International Limited of New Zealand
Vancouver, B.C., November 12th, 2025 – EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement
EnWave Signs Royalty-Bearing Commercial License with U.S. Snacking Company, Sells 10kW Radiant Energy Vacuum Machinery
Vancouver, B.C., November 10th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement

